Lotte Biologics chief

James Park, CEO of Lotte Biologics Co., the biotech arm of Lotte Group, attends a press conference in Yokohama, south of Tokyo, on Oct. 9, 2025, on the sidelines of Bio Japan 2025. (Yonhap)

(END)

[ⓒ K-VIBE. 무단전재-재배포 금지]